We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microbes Identified In Leukemic Febrile Neutropenia

By LabMedica International staff writers
Posted on 28 Jun 2022
Print article
Image: BD Bactec Media: Plus Aerobic/F were used to culture blood from Leukemic Febrile Neutropenia patients and compared to metagenomic shotgun sequencing (Photo courtesy of Fisher Scientific)
Image: BD Bactec Media: Plus Aerobic/F were used to culture blood from Leukemic Febrile Neutropenia patients and compared to metagenomic shotgun sequencing (Photo courtesy of Fisher Scientific)

Despite diagnostic advances in microbiology, the etiology of neutropenic fever remains elusive in most cases. Infectious complications of neutropenia occur in more than 80% of patients who undergo chemotherapy for hematological malignancy and 10% to 50% of those with visceral malignancies.

Bacteria are the most commonly detected microorganisms (10%–25%), followed by fungi (4%), with viruses being least commonly documented. Metagenomic shotgun sequencing is a blanket sequencing technique that has the potential to analyze all genetic material present in a sample. Over the last few years, metagenomic shotgun sequencing has been applied in clinical practice, and enabling detection of microorganisms not detected by conventional tests and even previously unrecognized human pathogens.

Infectious Disease Specialists at the Mayo Clinic College of Medicine and Science (Rochester, MN, USA) and their colleagues prospectively enrolled 20 acute leukemia patients and obtained blood from these patients at three time points: 1) anytime from onset of neutropenia until before development of neutropenic fever; 2) within 24 hours of onset of neutropenic fever; and 3) 5–7 days after onset of neutropenic fever.

Whole blood (5 mL) was collected in EDTA tubes (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) from each subject at the three time points. Blood cultures were performed using the Becton Dickinson BD BACTEC FX platform. A typical set consisted of two BD BACTEC Plus Aerobic/F bottles and one BD BACTEC Lytic Anaerobic/F bottle. Routinely, at least two blood culture sets are drawn per patient. Samples underwent nucleic acid extraction within four days of collection. Bacterial and viral fractions were spiked with internal controls (DNA phages for bacterial, and DNA and RNA phages for viral fractions) to assess assay quality. Sample preparation and nucleic acid extraction were performed using the iDTECT® Dx Blood test (PathoQuest, Paris, France).

The scientists reported that blood cultures grew a bacterium in three cases: Streptococcus mitis group in two and Leptotrichia species in one. Clinically relevant viruses or bacteria (CRVB) were present in three cases by metagenomic shotgun sequencing: rhinovirus in a subject with respiratory tract infection, Staphylococcus aureus in a subject with peri-anal cellulitis and Staphylococcus epidermidis in a subject with a potential bloodstream infection. Results of blood culture and metagenomic shotgun sequencing were discordant in all cases.

Besides blood culture results, three other subjects had positive microbiological laboratory tests, all from the respiratory tract. These included, respectively, rhinovirus and influenza A/respiratory syncytial virus infections in two subjects with upper respiratory tract infection, and a sputum culture for Pseudomonas aeruginosa in a subject with pneumonia.

The authors concluded that metagenomic shotgun sequencing could potentially be used as a supplement to standard tests to increase the yield of microbiological diagnosis. However, improvements in and optimization of sample preparation methods and sequencing platforms will be needed for widespread adoption of this approach into clinical practice. The study was published on June 16, 2022, in the journal PLOS ONE.

Related Links:
Mayo Clinic College of Medicine and Science 
Becton, Dickinson and Company 
PathoQuest 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Immunofluorescence Analyzer
MPQuanti
New
Coagulation Analyzer
CS-2400

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.